Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease

Abstract

Cells at the maternal-fetal interface express indoleamine 2,3 dioxygenase (IDO) to consume all local tryptophan for the express purpose of starving adjacent maternal T cells of this most limiting and essential amino acid. This stops local T cell proliferation to ultimately result in the most dramatic example of immune tolerance, acceptance of the fetus. By contrast, inhibition of IDO using 1-methyl-tryptophan causes a sudden catastrophic rejection of the mammalian fetus. Immunomodulatory factors including IFNgamma, TNFalpha, IL-1, and LPS use IDO induction in responsive antigen presenting cells (APCs) also to transmit tolerogenic signals to T cells. Thus it makes sense to consider IDO induction towards tolerance for autoimmune diseases in general. Approaches to cell specific therapeutic IDO induction with NAD precursor supplementation to prevent the collateral non-T cell pathogenesis due to chronic TNFalpha-IDO activated tryptophan depletion in autoimmune diseases are reviewed. Tryptophan is an essential amino acid most immediately because it is the only precursor for the endogenous biosynthesis of nicotinamide adenine dinucleotide (NAD). Both autoimmune disease and the NAD deficiency disease pellagra occur in women at greater than twice the frequency of occurrence in men. The importance of IDO dysregulation manifest as autoimmune pellagric dementia is genetically illustrated for Nasu-Hakola Disease (or PLOSL), which is caused by a mutation in the IDO antagonizing genes TYROBP/DAP12 or TREM2. Loss of function leads to psychotic symptoms rapidly progressing to presenile dementia likely due to unchecked increases in microglial IDO expression, which depletes neurons of tryptophan causing neurodegeneration. Administration of NAD precursors rescued entire mental hospitals of dementia patients literally overnight in the 1930's and NAD precursors should help Nasu-Hakola patients as well. NAD depletion mediated by peroxynitrate PARP1 activation is one of the few established mechanisms of necrosis. Chronic elevation of TNFalpha leading to necrotic events by NAD depletion in autoimmune disease likely occurs via combination of persistent IDO activation and iNOS-peroxynitrate activation of PARP1 both of which deplete NAD. Pharmacological doses of NAD precursors repeatedly provide dramatic therapeutic benefit for rheumatoid arthritis, type 1 diabetes, multiple sclerosis, colitis, other autoimmune diseases, and schizophrenia in either the clinic or animal models. Collectively these observations support the idea that autoimmune disease may in part be considered as localized pellagra manifesting symptoms particular to the inflamed target tissues. Thus pharmacological doses of NAD precursors (nicotinic acid/niacin, nicotinamide/niacinamide, or nicotinamide riboside) should be considered as potentially essential to the therapeutic success of any IDO-inducing regimen for treating autoimmune diseases. Distinct among the NAD precursors, nicotinic acid specifically activates the g-protein coupled receptor (GPCR) GPR109a to produce the...

Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis

“…It has been shown that stimulation of costimulatory molecules (CTLA-4 and CD80/86) or TLR upregulates IDO1 in inflammatory sites, through IFN-a-dependent pathways (19). Treatment of MBP-peptide-specific T cells with TLR3 agonist polyinosinicpolycytidylic acid significantly increased IDO expression (Fig.…”

Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons

“…Given the importance of intracellular NAD + levels for maintaining overall cellular integrity and function, it is conceivable that reduced NAD + levels are a potential pathogenic mechanism for neuronal and astroglial cell death 11,8. TRP has been used as a supplement for some years in the United States before being removed due to an outbreak of the lethal autoimmune disease, eosinophilia-myalgia syndrome (EMS) resulting in 36 deaths 11. Large doses of TRP can induce the build-up of selected white blood cells leading to EMS.…”

“…Essential NAD + dependent reactions can be divided into three main categories:2 (1) NAD + is an important contributor to energy (ATP) production;3 (2) NAD + serves as a cofactor for NAD glycohydrolases involved in intracellular calcium regulation;4,5 (3) NAD + is a substrate for the family of DNA nick sensing poly(ADP-ribose) polymerases (PARP)6–8 and the class III histone deacetylases known as sirtuins 9,10. NAD + levels are extremely volatile and can be significantly reduced under conditions of excessive PARP-1 activation caused by oxidative damage to DNA, and during mitosis 11. Thus, continuous biosynthesis of NAD + is vital to the maintenance and ongoing cell viability of all cells 12…”

Integrated stress response-altered pro-inflammatory signals in mucosal immune-related cells

“…IDO-1 also creates a hostile environment that prevents the invasion of microbes such as pathogenic bacteria and viruses 97 . Moreover, IDO-1 reduces pathogen growth and decreases asthma severity in a model of pulmonary disease activated by TLR9 agonists 98,99 .…”